Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

JAM‐A expression positively correlates with poor prognosis in breast cancer patients

7 Apr 2009

Abstract excerpt

The cell-cell adhesion protein junctional adhesion molecule-A (JAM-A) influences epithelial cell morphology and migration. As migration is required for tumor cell invasion and metastasis, we sought to elucidate the role of JAM-A in invasive breast cancer. A breast cancer tissue microarray was analyzed for JAM-A protein expression, in parallel with analysis of JAM-A gene expression data from a breast cancer...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Cells and Metastasis
Share to Cell Adhesion Molecules Research
Share to Cellular Mechanics and Interactions

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 19533747
DOI: 10.1002/ijc.24498

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

JAM‐A expression positively correlates with poor prognosis in breast cancer patientsPMID 19533747Read ↗

Identification and Validation of JAM-A as a Novel Prognostic and Immune Factor in Human TumorsSemantic proximity Read ↗

Abrogation of Junctional Adhesion Molecule-A Expression Induces Cell Apoptosis and Reduces Breast Cancer ProgressionSemantic proximity Read ↗

High expression of JAM2 indicates better prognosis and immunotherapy response in breast cancerSemantic proximity Read ↗

Junctional adhesion molecular 3 (JAM3) is a novel tumor suppressor and improves the prognosis in breast cancer brain metastasis via the TGF-β/Smad signal pathwaySemantic proximity Read ↗

Targeting Opposing Immunological Roles of the Junctional Adhesion Molecule-A in Autoimmunity and CancerSemantic proximity Read ↗

High-Throughput Flow Cytometry Screening Reveals a Role for Junctional Adhesion Molecule A as a Cancer Stem Cell Maintenance FactorSemantic proximity Read ↗

Characterization and chromosomal localization of JAM-1, a platelet receptor for a stimulatory monoclonal antibodySemantic proximity Read ↗

The Roles of Junctional Adhesion Molecules (JAMs) in Cell MigrationSemantic proximity Read ↗

Cooperative expression of junctional adhesion molecule‐C and ‐B supports growth and invasion of gliomaSemantic proximity Read ↗

Tetraspanin CD9 links junctional adhesion molecule-A to αvβ3 integrin to mediate basic fibroblast growth factor-specific angiogenic signaling.Semantic proximity Read ↗

MicroRNA 9-3p Targets β1 Integrin To Sensitize Claudin-Low Breast Cancer Cells to MEK InhibitionSemantic proximity Read ↗

Junctional adhesion molecule C (JAM-C) dimerization aids cancer cell migration and metastasis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.